Cetirizine Hydrochloride Injection(Shandong Kexin Huiyi Pharma)

盐酸西替利嗪注射液（山东科信惠益药业）

Report date: 2025/09/08 17:20:40

Base Information

Drug NameCetirizine Hydrochloride Injection(Shandong Kexin Huiyi Pharma)
Drug Alias NameCetrizet Hydrochloride盐酸西替立嗪Cetirizinum HydrochlorideCetirizina HydrochlorideKX7105 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsUrticaria
Global Approved IndicationsUrticaria
Approved Indications in ChinaUrticaria
Original Approved Country/TerritoryMainland China
Original Approved Date2024/06/28
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Kexin Huiyi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCosci Med-Tech Co Ltd
Inactive CompaniesChengdu Baiyu Pharmaceutical Co Ltd
Active IndicationsUrticaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG